Achilles Therapeutics plc announced the appointment of Alena Gros, Ph.D. and Ben Creelan, M.D. to its Scientific Advisory Board. Dr. Alena Gros is an internationally recognized expert in cancer immunology and immunotherapy, and currently serves as Principal Investigator of the Tumor Immunology and Immunotherapy Group at Vall d'Hebron Institute of Oncology in Barcelona, Spain. Dr. Ben Creelan is a leading medical oncologist and clinical and translational research physician in the thoracic oncology department at Moffitt Cancer Center, Tampa, FL.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.904 USD | +0.44% | -1.04% | +1.87% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.87% | 3.7Cr | |
+64.91% | 6.26TCr | |
-2.01% | 4.12TCr | |
+44.70% | 4.03TCr | |
-8.29% | 2.79TCr | |
+12.70% | 2.62TCr | |
-21.74% | 1.91TCr | |
+5.66% | 1.31TCr | |
+24.96% | 1.23TCr | |
+28.50% | 1.21TCr |
- Stock Market
- Equities
- ACHL Stock
- News Achilles Therapeutics plc
- Achilles Therapeutics plc Appoints Alena Gros and Ben Creelan to Its Scientific Advisory Board